Case Study — $250K Annual Savings Through White Label Optimisation

With the Australian medicinal cannabis market evolving rapidly over recent years, the industry is becoming increasingly competitive, commercially complex, and operationally demanding. For clinics and brands operating in the space, sustainable growth now relies not only on patient acquisition but on operational efficiency, supplier strategy, and commercial optimisation. We know this first hand, having recently partnered with a leading Australian medicinal cannabis clinic to restructure their white-label supply arrangements and improve the commercial performance of their business, resulting in —

• 50% reduction in cost of goods sold (COGS)

• Approximately $250,000.00 AUD in recurring annual savings

• Improved supplier alignment and operational efficiency

• No increase in patient numbers or marketing spend required

The Challenge

With a strong patient base and clinical reputation through offering multiple medicinal cannabis brands to patients, including their own white-label brand, our client had seen growth within the clinical side of the business. However, the commercial structure behind their white-labelled products had not evolved at the same pace, as the whitelabelling brand was operating under a third-party supplier arrangement with a profit-sharing model that had become increasingly inefficient as the business scaled. While suitable during the early stages of growth, the structure was no longer commercially aligned with the value the clinic was generating.

Although the clinic suspected stronger opportunities may have existed within the market, they lacked:

• Visibility into realistic supplier pricing

• Market benchmarking data

• Supplier negotiation leverage

• Access to the right industry relationships

• Strategic guidance around white labelling

This is where EQWELLIBRIYUM stepped in.

White Labelling in the Medicinal Cannabis Industry

White labelling has become one of the most commercially valuable strategies available to medicinal cannabis clinics in Australia.

When structured correctly, it can:

• Improve margins

• Strengthen patient retention

• Build long-term brand equity

• Provide greater control over supply chain relationships

• Create a more sustainable operating model

However, many clinics underestimate how relationship-driven and commercially nuanced the Australian medicinal cannabis supply chain can be.

Commercial outcomes vary significantly depending on:

• Supplier relationships

• Negotiation structures

• {roduct volume

• Pperational strategy

• Compliance considerations

Without deep market insight, many clinics simply accept supplier arrangements that are far from optimal because they are unaware that more attractive commercial terms may be available.

EQWELLIBRIYUM’s Strategic Approach

EQWELLIBRIYUM approached the engagement from both a commercial and operational perspective, including:

Commercial Review and Benchmarking

The first step involved reviewing the clinic’s existing supplier agreements and benchmarking their cost structure against broader Australian market conditions.

Using direct industry knowledge and supplier relationships, EQWELLIBRIYUM identified that the clinic’s COGS were significantly higher than what comparable operators were achieving.

This insight alone was highly valuable, as the clinic had no accurate visibility into:

• Achievable supplier pricing

• Whether their existing arrangement was competitive

• Hw much margin was being lost within the current structure

Supplier Introduction and Commercial Restructure

EQWELLIBRIYUM then introduced the clinic to a new licensed Australian medicinal cannabis supplier capable of manufacturing their white labelled product under substantially improved commercial terms, whereby the process included:

• Supplier sourcing

• Relationship facilitation

• Operational coordination

• Transition planning

• Compliance oversight

• Continuity management

Importantly, the supplier transition was managed end-to-end to ensure uninterrupted product supply, maintained clinical standards, and full TGA compliance throughout the process. Beyond supplier sourcing, EQWELLIBRIYUM also led the commercial negotiation and restructuring process to ensure the clinic’s:

• Sales volume

• Market position

• Operational contribution

• Long-term growth potential

were properly reflected within the commercial arrangement, resulting in an outcome of a significantly more sustainable and profitable operating model.

The Results

Following the restructure, the clinic achieved:

• A 50% reduction in cost of goods sold

• Approximately $250,000 in recurring annual savings

• Improved commercial control

• Stronger supplier alignment

• Enhanced operational scalability

• No need to profit share

Most importantly, these gains were achieved entirely on the clinic’s existing revenue base, where no additional patient growth was required, no significant marketing expansion was needed and no major operational overhaul was necessary.

The value already existed within the business — it simply required the right commercial structure and strategic approach to unlock it.

Key Takeaways for Whitelabelling

This case study highlights an increasingly important reality within the Australian medicinal cannabis industry:

Many clinics are operating on inefficient commercial structures without realising stronger opportunities may existms, whereby as the market matures, sustainable growth will increasingly come from:

• Operational optimisation

• Stronger supplier relationships

• Commercial efficiency

• Strategic procurement

• Scalable systems

• Long-term positioning

—not simply patient acquisition alone. Making it important to note that white labelling is not just about branding a product., because when structured correctly, it becomes a broader commercial strategy capable of significantly improving profitability, operational control, and long-term business sustainability.

Final Thoughts

The Australian medicinal cannabis industry is becoming more sophisticated — and more competitive.

The businesses that thrive over the next five years will not necessarily be the biggest, but the ones with:

• The strongest operational foundations

• She smartest supplier relationships

• The clearest strategic positioning

• The most commercially sustainable structures

Because sometimes the fastest way to grow a business isn’t adding more patients.

It’s restructuring the business you already have.

Learn More

At EQWELLIBRIYUM, we work with medicinal cannabis clinics, brands, pharmacies, and operators across Australia to help build smarter,  more profitable businesses in highly regulated healthcare industries.

We bring market insight, established supplier relationships, and commercial negotiation expertise to help healthcare businesses in highly regulated industries build smarter, more profitable operations.

If you operate a medicinal cannabis clinic or brand in Australia and want to understand what's available to your business — whether through white labelling, supplier restructuring, or broader commercial optimisation contact us at hello@eqwellibriyum.com to learn more.

Substitution Regulations Download

Sign up to our mailing list to receive a complimentary outline of the substitution regulations per state and territory within Australia.